Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Moser

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Discovery|March 3, 2025
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation CarriersSarah C Moser, Jos Jonkers
Genes & Development|November 7, 2024
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethalityAnna Khalizieva, Sarah C Moser, Peter Bouwman, et al.
Frontiers in Endocrinology|January 29, 2019
Osteocalcin-A Versatile Bone-Derived HormoneSarah C Moser, Bram C J van der Eerden
Nature Reviews. Clinical Oncology|July 21, 2021
Understanding and overcoming resistance to PARP inhibitors in cancer therapyMariana Paes Dias, Sarah C Moser, Shridar Ganesan, et al.
Frontiers in Immunology|January 24, 2018
Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I MoleculesSarah C Moser, Jane S A Voerman, Dennis L Buckley, et al.
Molecular Cell|November 18, 2017
Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYHAbdelghani Mazouzi, Federica Battistini, Sarah C Moser, et al.
Science Advances|May 31, 2023
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinksAbdelghani Mazouzi, Sarah C Moser, Federico Abascal, et al.
Cell Reports|March 19, 2025
SRBD1, a highly conserved gene required for chromosome individualizationJonne A Raaijmakers, Louise M E Janssen, Abdelghani Mazouzi, et al.
Nature|August 13, 2025
NASP modulates histone turnover to drive PARP inhibitor resistanceSarah C Moser, Anna Khalizieva, Josef Roehsner, et al.
Nature Communications|April 7, 2023
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancersPetra Ter Brugge, Sarah C Moser, Ivan Bièche, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Discovery|March 3, 2025
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation CarriersSarah C Moser, Jos Jonkers
Genes & Development|November 7, 2024
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethalityAnna Khalizieva, Sarah C Moser, Peter Bouwman, et al.
Frontiers in Endocrinology|January 29, 2019
Osteocalcin-A Versatile Bone-Derived HormoneSarah C Moser, Bram C J van der Eerden
Nature Reviews. Clinical Oncology|July 21, 2021
Understanding and overcoming resistance to PARP inhibitors in cancer therapyMariana Paes Dias, Sarah C Moser, Shridar Ganesan, et al.
Frontiers in Immunology|January 24, 2018
Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I MoleculesSarah C Moser, Jane S A Voerman, Dennis L Buckley, et al.
Molecular Cell|November 18, 2017
Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYHAbdelghani Mazouzi, Federica Battistini, Sarah C Moser, et al.
Science Advances|May 31, 2023
FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinksAbdelghani Mazouzi, Sarah C Moser, Federico Abascal, et al.
Cell Reports|March 19, 2025
SRBD1, a highly conserved gene required for chromosome individualizationJonne A Raaijmakers, Louise M E Janssen, Abdelghani Mazouzi, et al.
Nature|August 13, 2025
NASP modulates histone turnover to drive PARP inhibitor resistanceSarah C Moser, Anna Khalizieva, Josef Roehsner, et al.
Nature Communications|April 7, 2023
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancersPetra Ter Brugge, Sarah C Moser, Ivan Bièche, et al.
Pageof 1